Eleanor Health, a Waltham, MA-based outpatient addiction treatment provider, raised $30M in Series D funding.
The round was led by General Catalyst, with participation from existing and new investors including Town Hall Ventures, Echo Health Ventures, Northpond Ventures, Rethink Impact and Emerson Collective.
The company intends to use the funds to continue scaling its whole-person care model for substance use disorder.
Led by CEO William McKinney, Eleanor Health is an outpatient addiction treatment program. Its evidence-based care model takes a whole-person approach to treating adults with substance use disorder, addressing the physical, mental and psychosocial aspects of addiction. Its clinical model includes medications for addiction treatment, such as Suboxone and Vivitrol, psychiatry, therapy, and peer recovery coaching.
Eleanor is currently available in seven states (LA, MA, NJ, NC, OH, TX and WA).
FinSMEs
07/10/2024